Catalyst Wire Dossier Catalyst Wire Dossier

AVTR101

· Aventi Biotechnology Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AVTR101, covering 2025-04-09 to 2025-04-09. Get the full timeline:

Most recent: Clinical Trial Update: Study of Efficacy and Safety of AVTR101 in Sarcopenic Elderly [Phase 2]

See pricing